Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Zimmer Hip Replacement Lawyers: Network Zimmer Hip Replacement  Lawyer Win $2 Million Against Zimmer Hip Replacement Do You Have A Faulty Zimmer M/L Taper Hip Prothesis With Connective Technology and Cobalt Chromium Head? Do You Have Have Metallosis or Chromium Cobalt T...

Top Selling Drugs- Which Will Make It To An MDL Litigation

Written by lisaspitzer on . Posted in Drug Lawsuits, Drug Warnings, Drugs and Devices lawsuit attorneys

With new drugs coming out each month and many becoming best sellers we wonder which of these will start to implicate the manufacturer for lack of warnings for a medical condition.  We already know that Xarelto has lawsuits for excessive bleeding and Yaz just reached a settlement for causing blood clots and related medical conditions. According to Medscape Medical news the cholesterol-lowering drug rosuvastatin (Crestor, AstraZeneca) has been the  most prescribed branded drug in the United States, and the arthritis drug adalimumab (Humira, Abbott Laboratories) was the best-selling branded drug, according to the latest data from research firm IMS Health. Rosuvastatin had about 21 million prescriptions, followed by asthma medication fluticasone propionate/salmeterol (Advair Diskus, GlaxoSmithKline), at about 13.6 million prescriptions; the proton pump inhibitor esomeprazole (Nexium, AstraZeneca), at about 13.2 million prescriptions; the insulin glargine injection Lantus Solostar (sanofi-aventis), at about 11.2 million; and the attention-deficit drug lisdexamfetamine dimesylate (Vyvanse, Shire), at about 10.6 million. Rounding out the top 10 most prescribed drugs for the period (in order) were the antiepileptic drug pregabalin (Lyrica, Pfizer), the chronic obstructive pulmonary disease medication tiotropium bromide (Spiriva Handihaler, Boehringer Ingelheim Pharmaceuticals), the diabetes drug sitagliptin (Januvia, Merck), the asthma/chronic obstructive pulmonary disease drug budesonide/formoterol (Symbicort, AstraZeneca), and the antipsychotic medication aripiprazole (Abilify, Otsuka Pharmaceutical). Top Sellers The top seller, arthritis drug adalimumab (Humira, Abbott Laboratories), had sales of about $8.6 billion, followed by the antipsychotic aripiprazole (Abilify, Otsuka Pharmaceutical), at $7.2 billion; the arthritis drug etanercept (Enbrel, Amgen), at roughly $6.1 billion; the cholesterol drug rosuvastatin (Crestor, AstraZeneca), at just under $6.1 billion; and the insulin glargine injection Lantus Solostar (sanofi-aventis), at around $5 billion. The remaining top 10 drugs in sales were the hepatitis C drug sofosbuvir (Sovaldi, Gilead Sciences), at $4.9 billion; the asthma drug fluticasone propionate/salmeterol (Advair Diskus, GlaxoSmithKline), at $4.8 billion; the proton pump inhibitor esomeprazole (Nexium, AstraZeneca), at $4.7 billion; the diabetes drug sitagliptin (Januvia, Merck), at $3.8 billion; and the antiepileptic pregabalin (Lyrica, Pfizer), at $3.4 billion. Top 100 Brands by Sales Product Sales, $ Humira $8,566,451,647 Abilify $7,238,451,779 Current lawsuits by Abilify lawyers Enbrel $6,139,812,530 Crestor $6,090,223,570 Lantus Solostar $5,023,092,599 Sovaldi $4,925,098,469 Advair Diskus $4,769,250,836 Nexium $4,709,542,900 Januvia $3,792,531,657  Current lawsuits pending Lyrica $3,442,755,962 Spiriva Handihaler $3,388,442,306 Symbicort $2,480,108,204 Xarelto $2,460,606,162 Current lawsuits pending Vyvanse $2,255,494,506 Novolog Flexpen $2,212,204,664 Zetia $2,155,848,498 Stelara $1,781,288,922 Prevnar $1,746,605,006 Humalog Kwikpen $1,588,639,456 Gilenya $1,577,027,870 Cialis $1,520,551,442 Restasis $1,410,652,178 Latuda $1,379,675,847 Viagra $1,375,305,952 Recent lawsuits  for Melanoma Seroquel XR $1,359,121,073 Celebrex $1,323,059,229 Invokana $1,254,451,641 Orencia $1,188,411,778 Androgel $1,182,514,119 Current lawsuits pending Nasonex $1,124,061,350 Tamiflu $1,050,683,805 Vesicare $1,040,724,740 Eliquis $964,121,283 Cimzia $933,953,154 Namenda XR $857,157,299 Levemir $851,149,040 Pradaxa $850,313,699 Current lawsuits pending- Pradaxa lawyers Prolia $817,906,368 Pristiq $750,241,124 Nuvaring $690,996,076 Nuvaring lawyers Zostavax $686,790,521 Dulera $669,637,717 Gardasil $659,747,125 Exelon $647,136,515 Simponi $608,898,230 Mirena $603,038,710 Lawsuits and MDL- Mirena IUD Lawyers Onglyza $579,325,631 Linzess $515,749,802 Premarin $493,812,315 Intuniv $489,285,664 Chantix $472,869,473 Avodart $471,499,125 Xeljanz $413,374,592 Uloric $411,824,301 Farxiga $410,997,209 Myrbetriq $408,957,063 Premarin Vaginal $397,570,841 Epipen Jr 2-Pak $389,528,868 Vimovo $368,883,419 Epiduo $349,457,182 Relpax $331,629,578 Nexplanon $301,889,830 Aczone $278,671,485 Lovaza $259,812,629 Lipitor $251,981,518 Axiron $233,871,526 Cymbalta $223,291,761 Toviaz $219,986,729 Livalo $185,479,248 Jublia $178,047,175 Actonel $152,123,935 Breo Ellipta $140,349,328 Flumist $131,614,245 Xiaflex $127,063,110 Quillivant XR $107,092,690 Belviq $96,038,704 Aciphex $91,853,217 Latisse $82,671,844 Lunesta $79,894,370 Singulair $78,256,791 Niaspan $71,761,121 Estring $71,006,566 Anoro Ellipta $64,460,164 Plavix $52,762,015 Botox $51,501,869 Yaz-28 $49,432,035 Yas lawyers- settlement just announced Osphena $49,034,121 Ambien CR $45,955,805 Aricept $26,773,067 Brisdelle $22,581,016 Omnaris $19,352,785 Flomax $18,139,072 Trilipix $16,459,450 Boniva $16,056,457 Boniva lawyers filing lawsuits Caduet $14,166,476 Duavee $13,567,296 Reclast $11,208,523 Lawsuits being filed Seasonique $11,101,960 Botox Cosmetic $952,021 Victoza Unsp N-N Grand total $112,494,804,575 article courtesy of Medscape Medical News © 2015 WebMD, LLC        

Tags: , ,